PUBLISHER: Grand View Research | PRODUCT CODE: 1301189
PUBLISHER: Grand View Research | PRODUCT CODE: 1301189
The global sperm bank market size is expected to reach USD 6.6 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.56% over the forecast period. The market is majorly driven by increasing incidence of male and female infertility, rising acceptance of sperm banking services, and government initiatives in Assisted Reproductive Techniques (ART). Furthermore, increasing number of couples are planning to start family at later phase and hence are freezing their gametes. This is also contributing to the market expansion.
In women, rate of infertility decreases with age. Risks of complications during pregnancy also increase with age, resulting in the use of donor sperms or eggs. Rising trend of smoking is also affecting fertility in males and females. Female smokers achieve menopause earlier as compared to nonsmokers and are also at higher risk of miscarriage. In recent years, socioeconomic and demographic trends have increased the number of females seeking pregnancy during their late 30s and mid-40s. This also represents lucrative opportunities for the market growth.
Rise in funding and supportive initiatives for ART has driven growth of the market. For instance, the Australian government funds the ART services under the Medicare Benefit Scheme. It supports the access to In vitro Fertilization (IVF) or ART for the people unable to have children. Other countries with supportive initiatives include U.K., Singapore, and Canada. Growing acceptance of Lesbian, Gay, Bisexual, and Transgender (LGBT) community is also a key market driver. This represents growing demand for sperm banking services in the country.
The COVID-19 pandemic adversely impacted the market. There was a decrease in number of sperm donations owing to travel restrictions and social distancing norms. The number IVF and ART procedures also declined, resulting in decrease demand for donor sperm. In response to the pandemic many fertility centers and sperm banks suspended initiation of treatment cycles and elective gamete cryopreservation.